journal
Journals International Journal of Cance...

International Journal of Cancer. Journal International du Cancer

https://read.qxmd.com/read/38651675/a-nested-case-control-study-of-untargeted-plasma-metabolomics-and-lung-cancer-among-never-smoking-women-within-the-prospective-shanghai-women-s-health-study
#1
JOURNAL ARTICLE
Mohammad L Rahman, Xiao-Ou Shu, Dean P Jones, Wei Hu, Bu-Tian Ji, Batel Blechter, Jason Y Y Wong, Qiuyin Cai, Gong Yang, Yu-Tang Gao, Wei Zheng, Nathaniel Rothman, Douglas Walker, Qing Lan
The etiology of lung cancer in never-smokers remains elusive, despite 15% of lung cancer cases in men and 53% in women worldwide being unrelated to smoking. Here, we aimed to enhance our understanding of lung cancer pathogenesis among never-smokers using untargeted metabolomics. This nested case-control study included 395 never-smoking women who developed lung cancer and 395 matched never-smoking cancer-free women from the prospective Shanghai Women's Health Study with 15,353 metabolic features quantified in pre-diagnostic plasma using liquid chromatography high-resolution mass spectrometry...
April 23, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38648390/effectiveness-of-self-sampling-human-papillomavirus-test-on-precancer-detection-and-screening-uptake-in-japan-the-access-randomized-controlled-trial
#2
JOURNAL ARTICLE
Misuzu Fujita, Kengo Nagashima, Minobu Shimazu, Misae Suzuki, Ichiro Tauchi, Miwa Sakuma, Setsuko Yamamoto, Hideki Hanaoka, Makio Shozu, Nobuhide Tsuruoka, Tokuzo Kasai, Akira Hata
Japan is lagging in cervical cancer prevention. The effectiveness of a self-sampling human papillomavirus (HPV) test, a possible measure to overcome this situation, has not yet been evaluated. A randomized controlled trial was performed to evaluate the effectiveness of a self-sampling HPV test on detection of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) and screening uptake. Women between 30 and 58 years old who did not participate in the cervical cancer screening program for ≥3 years were eligible and assigned to the intervention group (cytology or self-sampling HPV test) or control group (cytology)...
April 22, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38648387/cancer-associated-fibroblast-activation-predicts-progression-metastasis-and-prognosis-of-cutaneous-squamous-cell-carcinoma
#3
JOURNAL ARTICLE
Jaakko S Knuutila, Pilvi Riihilä, Liisa Nissinen, Lauri Heiskanen, Roosa E Kallionpää, Teijo Pellinen, Veli-Matti Kähäri
Cutaneous squamous cell carcinoma (cSCC) is the most common metastatic skin cancer and the metastatic disease is associated with poor prognosis. Cancer-associated fibroblasts (CAFs) promote progression of cancer, but their role in cSCC is largely unknown. We examined the potential of CAF markers in the assessment of metastasis risk and prognosis of primary cSCC. We utilized multiplexed fluorescence immunohistochemistry for profiling CAF landscape in metastatic and non-metastatic primary human cSCCs, in metastases, and in premalignant epidermal lesions...
April 22, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38648380/assessment-of-barriers-to-cancer-screening-and-interventions-implemented-to-overcome-these-barriers-in-27-latin-american-and-caribbean-countries
#4
JOURNAL ARTICLE
Isabel Mosquera, Clara B Barajas, Hannah Theriault, Sara Benitez Majano, Li Zhang, Mauricio Maza, Silvana Luciani, Andre L Carvalho, Partha Basu
There is a gap in the understanding of the barriers to cancer screening participation and complying with downstream management in the Community of Latin American and Caribbean states (CELAC). Our study aimed to assess barriers across the cancer screening pathway from the health system perspective, and interventions in place to improve screening in CELAC. A standardized tool was used to collect information on the barriers across the screening pathway through engagement with the health authorities of 27 member states of CELAC...
April 22, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38647131/metabolic-characterization-of-sphere-derived-prostate-cancer-stem-cells-reveals-aberrant-urea-cycle-in-stemness-maintenance
#5
JOURNAL ARTICLE
Yuanyuan Luo, Jiachuan Yu, Zhikun Lin, Xiaolin Wang, Jinhui Zhao, Xinyu Liu, Wangshu Qin, Guowang Xu
Alteration of cell metabolism is one of the essential characteristics of tumor growth. Cancer stem cells (CSCs) are the initiating cells of tumorigenesis, proliferation, recurrence, and other processes, and play an important role in therapeutic resistance and metastasis. Thus, identification of the metabolic profiles in prostate cancer stem cells (PCSCs) is critical to understanding prostate cancer progression. Using untargeted metabolomics and lipidomics methods, we show distinct metabolic differences between prostate cancer cells and PCSCs...
April 22, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38642029/outcome-of-early-detection-approach-in-control-of-breast-cervical-and-oral-cancer-experience-from-a-rural-cancer-center-in-india
#6
JOURNAL ARTICLE
Atul Budukh, Tapas Dora, Sankalp Sancheti, Vikram Singh, Alok Goel, Sonali Bagal, Amandeep Kaur, Ishan Manchanda, Gurwinder Kaur, Ashish Gulia, Pankaj Chaturvedi, Rajendra Badwe
In low- and middle-income countries most of the cancer patients attend the hospital at a late stage and treatment completion of these cases is challenging. The early detection program (EDP), in rural areas of Punjab state, India was initiated to identify breast, cervical, and oral cancer at an early stage by raising awareness and providing easy access to diagnosis and treatment. A total of 361 health education programs and 99 early detection clinics were organized. The symptomatic and self-interested (non-symptomatic individuals who opted for screening) cases visited the detection clinic...
April 20, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38630934/elapor1-induces-the-classical-progenitor-subtype-and-contributes-to-reduced-disease-aggressiveness-through-metabolic-reprogramming-in-pancreatic-cancer
#7
JOURNAL ARTICLE
Yuuki Ohara, Huaitian Liu, Amanda J Craig, Shouhui Yang, Paloma Moreno, Tiffany H Dorsey, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael Ghadimi, Nader Hanna, Stefan Ambs, S Perwez Hussain
Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease with distinct molecular subtypes described as classical/progenitor and basal-like/squamous PDAC. We hypothesized that integrative transcriptome and metabolome approaches can identify candidate genes whose inactivation contributes to the development of the aggressive basal-like/squamous subtype. Using our integrated approach, we identified endosome-lysosome associated apoptosis and autophagy regulator 1 (ELAPOR1/KIAA1324) as a candidate tumor suppressor in both our NCI-UMD-German cohort and additional validation cohorts...
April 17, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38623608/beyond-basics-key-mutation-selection-features-for-successful-tumor-informed-ctdna-detection
#8
JOURNAL ARTICLE
Marijana Nesic, Mads H Rasmussen, Tenna V Henriksen, Christina Demuth, Amanda Frydendahl, Iver Nordentoft, Lars Dyrskjøt, Claus L Andersen
Tumor-informed mutation-based approaches are frequently used for detection of circulating tumor DNA (ctDNA). Not all mutations make equally effective ctDNA markers. The objective was to explore if prioritizing mutations using mutational features-such as cancer cell fraction (CCF), multiplicity, and error rate-would improve the success rate of tumor-informed ctDNA analysis. Additionally, we aimed to develop a practical and easily implementable analysis pipeline for identifying and prioritizing candidate mutations from whole-exome sequencing (WES) data...
April 16, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38619193/association-between-cdk4-6-inhibitors-and-drug-related-osteonecrosis-of-the-jaw-a-pharmacoepidemiological-study-using-the-fda-adverse-events-reporting-system
#9
JOURNAL ARTICLE
Makiko Go, Yoshihiro Noguchi, Rikuto Masuda, Hiroki Asano, Michio Kimura, Eiseki Usami, Tomoaki Yoshimura
The most common toxicities associated with cyclin-dependent kinase (CDK) 4/6 inhibitor therapy include decreased leukopenia and neutropenia due to the inhibition of CDK6 of leukocyte and neutrophil precursors in bone marrow. These hematological toxicities are more commonly observed with palbociclib administration than with abemaciclib administration, which is approximately 13 times more selective against CDK4 than CDK6. Thus, even though both successfully inhibit CDK4/6, the side effects of palbociclib and abemaciclib differ due to differences in selectivity...
April 15, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38619111/parp1-expression-predicts-parp-inhibitor-sensitivity-and-correlates-with-metastatic-potential-and-overall-survival-in-melanoma
#10
JOURNAL ARTICLE
Lisa Marie Fröhlich, Ana Villar-Miyar, Tamara Heintze, Birgit Sauer, Birgit Schittek
Metastatic melanoma is still a difficult-to-treat cancer type owing to its frequent resistance mechanisms to targeted and immunotherapy. Therefore, we aimed to unravel novel therapeutic strategies for melanoma patients. Preclinical and clinical studies show that melanoma patients may benefit from a treatment with poly (ADP-ribose) polymerase (PARP) inhibitors (PARPi). In this study, we focus on PARP1 as a potential biomarker to predict the response of melanoma cells to PARPi therapy. We found that melanoma cells with high basal PARP1 expression exhibit significantly increased cell death after PARPi treatment owing to higher PARP1 trapping compared with melanoma cells with low PARP1 expression...
April 15, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38613405/comprehensive-characterization-of-somatic-mutations-associated-with-chimeric-rnas-in-human-cancers
#11
JOURNAL ARTICLE
Yuting Wang, Meng Shu, Tianqiang Wang, Tongxin He, Jiapei Yuan, Yang Yang
Chimeric RNAs, which can arise from gene recombination at the DNA level or non-canonical splicing events at the RNA level, have been identified as important roles in human tumors. Dysregulated gene expression caused by somatic mutations and altered splicing patterns of oncogenes or tumor suppressor genes can contribute to the development of tumors. Therefore, investigating the formation mechanism of chimeric RNAs via somatic mutations is critical for understanding tumor pathogenesis. This project is the first to propose studying the association between somatic single nucleotide variants and chimeric RNAs, identifying around 2900 somatic SNVs affecting chimeric RNAs in pan-cancer level...
April 13, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38608177/chemotherapy-versus-chemotherapy-plus-immune-checkpoint-inhibitors-for-the-first-line-treatment-of-unresectable-thymic-carcinoma-a-multicenter-retrospective-study
#12
JOURNAL ARTICLE
Baishen Zhang, Yao Liu, Zhiting Chen, Jing Chen, Hui Yu, Meichen Li, Shudong Ma, Chao Cheng, Likun Chen
Thymic carcinoma (TC) is a rare malignant tumor with a poor prognosis, and there is currently limited data on the use of immunotherapy in patients with unresectable TC. In this study, data of patients with unresectable TC diagnosed from January 2017 were retrospectively collected from multiple centers. Treatment response, progression-free survival (PFS), overall survival (OS), survival-independent prognostic factor, and adverse events (AEs) were further analyzed. As a result, a total of 93 patients with unresectable TC were enrolled, of which 54 received first-line chemotherapy, and 39 received chemotherapy plus immune checkpoint inhibitors (ICIs)...
April 12, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38608173/prevalence-of-survivors-of-childhood-cancer-based-on-a-population-based-cancer-registry-in-osaka-japan
#13
JOURNAL ARTICLE
Haruka Kudo, Kayo Nakata, Toshitaka Morishima, Mizuki Shimadzu Kato, Yoshihiro Kuwabara, Akihisa Sawada, Hiroyuki Fujisaki, Yoshiko Hashii, Isao Miyashiro
Although the survival rate of patients with childhood cancer has greatly improved, long-term survivors face specific problems such as the late effects of cancer treatment. In this study, we estimated the number of people who had experienced childhood cancer to predict their needs for medical care and social resources. Using data from the population-based Osaka Cancer Registry, we identified children aged 0-14 years who were diagnosed with cancer between 1975 and 2019. We estimated the prevalence on December 31, 2019, and the 5- and 10-year prevalence (i...
April 12, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38602070/circulating-micrornas-in-association-with-pancreatic-cancer-risk-within-5%C3%A2-years
#14
JOURNAL ARTICLE
Cong Wang, Hui Cai, Qiuyin Cai, Jie Wu, Rachael Stolzenberg-Solomon, Xingyi Guo, Claire Zhu, Yu-Tang Gao, Jordan Berlin, Fei Ye, Wei Zheng, Veronica Wendy Setiawan, Xiao-Ou Shu
Early detection is critical for improving pancreatic cancer prognosis. Our study aims to identify circulating microRNAs (miRNAs) associated with pancreatic cancer risk. The two-stage study used plasma samples collected ≤5 years prior to cancer diagnosis, from case-control studies nested in five prospective cohort studies. The discovery stage included 185 case-control pairs from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Replication stage samples comprised 277 pairs from Shanghai Women's Health Study/Shanghai Men's Health Study, Southern Community Cohort Study, and Multiethnic Cohort Study...
April 11, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38602058/exploring-the-tumor-genomic-landscape-of-aggressive-prostate-cancer-by-whole-genome-sequencing-of-tissue-or-liquid-biopsies
#15
JOURNAL ARTICLE
Simone Weiss, Philippe Lamy, Maria Rusan, Maibritt Nørgaard, Benedicte Parm Ulhøi, Michael Knudsen, Christine Gaasdal Kassentoft, Leila Farajzadeh, Jørgen Bjerggaard Jensen, Jakob Skou Pedersen, Michael Borre, Karina Dalsgaard Sørensen
Treatment resistance remains a major issue in aggressive prostate cancer (PC), and novel genomic biomarkers may guide better treatment selection. Circulating tumor DNA (ctDNA) can provide minimally invasive information about tumor genomes, but the genomic landscape of aggressive PC based on whole-genome sequencing (WGS) of ctDNA remains incompletely characterized. Thus, we here performed WGS of tumor tissue (n = 31) or plasma ctDNA (n = 10) from a total of 41 aggressive PC patients, including 11 hormone-naïve, 15 hormone-sensitive, and 15 castration-resistant patients...
April 11, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38602045/field-experience-with-the-8-hpv-type-oncoprotein-test-for-cervical-cancer-screening-among-hpv-positive-women-living-with-and-without-hiv-in-lmics
#16
JOURNAL ARTICLE
Laura Downham, Mary Luz Rol, Mathilde Forestier, Pilar Romero, Laura Mendoza, Pamela Mongelós, María Alejandra Picconi, María Celeste Colucci, Valeria Mariel Padin, Ana Paula Flores, Michael Zúñiga, Annabelle Ferrera, Yessy Cabrera, Marcela Farfan Crispín, Arianis Tatiana Ramirez, Londiwe Cele, Halimatou Diop-Ndiaye, Dianke Samaté, Pascaline Manga, Fadimatou Bintou Thiam, Maria Isabel Rodriguez, Jyoshma P DSouza, Victoria Nyawira Nyaga, Mamadou Diop, Motshedisi Sebitloane, Gloria Inés Sánchez, Carolina Teran, Alejandro Calderon, Carolina Wiesner, Raul Murillo, Rolando Herrero, Armando Baena, Maribel Almonte
Overexpression of HPV-oncoproteins E6 and E7 is necessary for HPV-driven cervical carcinogenesis. Hence, these oncoproteins are promising disease-specific biomarkers. We assessed the technical and operational characteristics of the 8-HPV-type OncoE6/E7 Cervical Test in different laboratories using cervical samples from HPV-positive women living with (WLWH) and without HIV. The 8-HPV-type OncoE6/E7 Test (for short: "OncoE6/E7 test") was performed in 2833 HIV-negative women and 241 WLWH attending multicentric studies in Latin America (ESTAMPA study), and in Africa (CESTA study)...
April 11, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38598851/effects-of-ambient-temperature-relative-humidity-and-absolute-humidity-on-risk-of-nasopharyngeal-carcinoma-in-china
#17
JOURNAL ARTICLE
Wenyi Di, Jiamin Yu, Dan Zong, Yizhi Ge, Yujie Zhang, Xin Chen, Xia He
Nasopharyngeal carcinoma (NPC) has a unique geographic distribution. It is unknown whether meteorological factors are related to the incidence of NPC. To investigate the effect of ambient temperature, relative humidity (RH), and absolute humidity (AH) on the incidence of NPC, we collected the incidence rate of NPC in 2016 and meteorological data from 2006 to 2016 from 484 cities and counties across 31 provinces in China. Generalized additive models with quasi-Poisson regression and generalized linear models with natural cubic splines were employed respectively to elucidate the nonlinear relationships and specify the partial linear relationships...
April 10, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38594805/prognosis-and-immunotherapy-efficacy-in-dmmr-mss-colorectal-cancer-patients-and-an-msi-status-predicting-model
#18
JOURNAL ARTICLE
Xinhui Fu, Jinglin Huang, Junling Zhu, Xinjuan Fan, Chao Wang, Weihao Deng, Xiaoli Tan, Zhiting Chen, Yacheng Cai, Hanjie Lin, Guannan Wang, Ning Zhang, Yongmin Zhu, Ji Chen, Huanmiao Zhan, Shuhui Huang, Yongzhen Fang, Yuhua Li, Yan Huang
The inconsistency between mismatch repair (MMR) protein immunohistochemistry (IHC) and microsatellite instability PCR (MSI-PCR) methods has been widely reported. We aim to investigate the prognosis and the effect of immunotherapy in dMMR by IHC but MSS by MSI-PCR (dMMR&MSS) colorectal cancer (CRC) patients. A microsatellite instability (MSI) predicting model was established to help find dMMR&MSS patients. MMR and MSI states were detected by the IHC and MSI-PCR in 1622 CRC patients (ZS6Y-1 cohort). Logistic regression analysis was used to screen clinical features to construct an MSI-predicting nomogram...
April 9, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38577898/differences-in-survival-and-recurrence-of-colorectal-cancer-by-stage-across-population-based-european-registries
#19
JOURNAL ARTICLE
Anne-Marie Bouvier, Valérie Jooste, Roberto Lillini, Rafael Marcos-Gragera, Alexander Katalinic, Paolo Giorgi Rossi, Guy Launoy, Véronique Bouvier, Marcela Guevara, Eva Ardanaz, Elisabetta Rapiti Aylward, Kaire Innos, Miguel Rodríguez Barranco, Milena Sant
Recurrence after colorectal cancer resection is rarely documented in the general population while a key clinical determinant for patient survival. We identified 8785 patients with colorectal cancer diagnosed between 2010 and 2013 and clinically followed up to 2020 in 15 cancer registries from seven European countries (Bulgaria, Switzerland, Germany, Estonia, France, Italy, and Spain). We estimated world age-standardized net survival using a flexible cumulative excess hazard model. Recurrence rates were calculated for patients with initially resected stage I, II, or III cancer in six countries, using the actuarial survival method...
April 5, 2024: International Journal of Cancer. Journal International du Cancer
https://read.qxmd.com/read/38577882/clinical-efficacy-of-tumor-organoid-guided-cancer-therapy-for-locally-advanced-unresectable-or-metastatic-breast-cancer
#20
JOURNAL ARTICLE
Ying-Yi Lin, Hong-Fei Gao, Hong Li, Qiong Hu, Bo-le Du, Sheng Li, Fang-Ping Xu, Min-Yi Cheng, Jia-Chen Zou, Xing-Xing Zheng, Teng Zhu, Kun Wang
Patient-derived organoids (PDOs) may facilitate treatment selection. This retrospective cohort study evaluated the feasibility and clinical benefit of using PDOs to guide personalized treatment in metastatic breast cancer (MBC). Patients diagnosed with MBC were recruited between January 2019 and August 2022. PDOs were established and the efficacy of customized drug panels was determined by measuring cell mortality after drug exposure. Patients receiving organoid-guided treatment (OGT) were matched 1:2 by nearest neighbor propensity scores with patients receiving treatment of physician's choice (TPC)...
April 5, 2024: International Journal of Cancer. Journal International du Cancer
journal
journal
21282
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.